Department of Psychology, San Diego State University, San Diego, CA, USA.
School of Nursing, University of Pennsylvania, Philadelphia, PA, USA.
Curr HIV/AIDS Rep. 2020 Aug;17(4):269-280. doi: 10.1007/s11904-020-00506-1.
PURPOSE OF REVIEW: The purpose of this review is to describe and assess the literature on mobile health (mHealth) and other technology-based HIV testing interventions published in the 5-year period from 2015 to 2020. RECENT FINDINGS: We identified 18 published technology-based studies, 6 of which were efficacy trials and the remaining 12 were either pilot randomized controlled trials (RCTs) or quasi-experimental studies. Most (n = 10) interventions were conducted outside the USA, including countries in Sub-Saharan Africa (n = 4), China (n = 3), Latin America (n = 2), and India (n = 1). All efficacy trials showed some evidence of efficacy, although uptake of HIV testing was low among in intervention trials that consisted of a low number of text messages. Most pilot RCTs demonstrated high levels of feasibility and acceptability, as well as some evidence that the intervention participants benefited more than the control group. Many non-randomized trials similarly reported positive appraisal by study participants. Recommendations for future research and practice by the authors of the studies reviewed here are summarized. Technology-assisted HIV testing interventions may be an important strategy to reach national and global targets for HIV status awareness in the general population and for most at-risk groups. Although there appears to be growing evidence of their benefit, questions linger regarding how to leverage existing social media platforms to promote HIV testing, which interventions work for what populations, and best practices for scaling up mHealth and other technology-based interventions.
目的综述:本综述旨在描述并评估 2015 年至 2020 年 5 年间发表的关于移动医疗(mHealth)和其他基于技术的 HIV 检测干预措施的文献。
最新发现:我们确定了 18 项已发表的基于技术的研究,其中 6 项为疗效试验,其余 12 项为试点随机对照试验(RCT)或准实验研究。大多数(n=10)干预措施是在美国境外进行的,包括撒哈拉以南非洲国家(n=4)、中国(n=3)、拉丁美洲(n=2)和印度(n=1)。所有疗效试验都表明有一定的疗效证据,尽管在由少量短信组成的干预试验中,HIV 检测的接受率较低。大多数试点 RCT 都证明了高可行性和可接受性,以及一些证据表明,与对照组相比,干预参与者受益更多。许多非随机试验也同样报告了研究参与者的积极评价。这里回顾的研究的作者总结了对未来研究和实践的建议。技术辅助的 HIV 检测干预措施可能是实现国家和全球目标的重要策略,即提高一般人群和大多数高危人群对 HIV 状况的认识。尽管越来越多的证据表明其具有益处,但仍存在一些问题,例如如何利用现有的社交媒体平台来促进 HIV 检测、哪些干预措施对哪些人群有效,以及扩大 mHealth 和其他基于技术的干预措施的最佳实践。
Curr HIV/AIDS Rep. 2020-8
Cochrane Database Syst Rev. 2012-12-12
Cochrane Database Syst Rev. 2008-7-16
Cochrane Database Syst Rev. 2017-12-22
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2018-8-15
Cochrane Database Syst Rev. 2011-3-16
J Med Internet Res. 2025-4-28
Front Health Serv. 2023-10-31
AIDS Behav. 2020-11
MMWR Morb Mortal Wkly Rep. 2019-12-6
Curr HIV/AIDS Rep. 2019-12
AIDS Behav. 2020-2
Glob Public Health. 2019-6-21